Clinical Update
Potential role of EGb 761® in combination with AChEI in patients with mild cognitive impairment
A neurocognitive condition between normal ageing and dementia is known as mild cognitive impairment (MCI). The frequency of MCI in the population of people aged 60 years and older varies greatly. Numerous risk factors, such as genetics, comorbidities, and vascular risk factors like hypertension or diabetes, depression, and tobacco use, affect its development in addition to age.
Other review articles: